CDX2 and cholangiocarcinoma: For instance, it has been reported that immunostaining for cytokeratin (CK) 7, CK19, CK20, and caudal type homeobox 2 (CDX2) is useful in distinguishing CCA from metastatic liver cancer [12,13].